Multiple Sclerosis Discovery Forum

Inspiring Connections

Most Viewed

Cerebral hypoperfusion in multiple sclerosis is reversible and mediated by endothelin-1.
Standardized magnetic resonance imaging acquisition and reporting in pediatric multiple sclerosis.
Identifying the amylome, proteins capable of forming amyloid-like fibrils.
Alteration of prolyl oligopeptidase and activated alpha-2-macroglobulin in multiple sclerosis subtypes and in the clinically isolated syndrome.
Early White Matter Changes in Childhood Multiple Sclerosis: A Diffusion Tensor Imaging Study.
Is It Too Early to Predict the Failure of Natalizumab in NMO?-Reply.
S-Allylmercapto-N-acetylcysteine (ASSNAC) protects cultured nerve cells from oxidative stress and attenuates experimental autoimmune encephalomyelitis.
Dermatoglyphic features in patients with multiple sclerosis.
Helicobacter pylori infection as a protective factor against multiple sclerosis risk in females.
Spinal cord tumour misdiagnosed as seropositive neuromyelitis optica spectrum disorder.
Intestinal Microbiota as Modulators of the Immune System and Neuroimmune System: Impact on the Host Health and Homeostasis.
Timing of use of cod liver oil, a vitamin D source, and multiple sclerosis risk: The EnvIMS study.
Examination of Cognitive Fatigue in Multiple Sclerosis using Functional Magnetic Resonance Imaging and Diffusion Tensor Imaging.
Novel molecular insights into classical and alternative activation states of microglia as revealed by SILAC-based proteomics.
The ethics of placebo controlled clinical trials in NMO - A balance of risks.
Fulminant Demyelinating Diseases of the Central Nervous System.
Obstructive sleep apnea is associated with fatigue in multiple sclerosis.
Relationship between subjective and objective cognitive performance in multiple sclerosis.
A Case of Anti-aquaporin-4 Antibody-Seronegative NMO Spectrum Disorder with Baló Concentric Lesions.
Intermediate uveitis in children and young adults: differences in clinical course, associations and visual outcome.
Long-term suppression of EAE relapses by pharmacological impairment of epitope spreading.
Genetic variants in IL2RA and IL7R affect multiple sclerosis disease risk and progression.
Comment on 'Fingolimod to treat severe MS after natalizumab-associated progressive multifocal leukoencephalopathy: a valid option?' Maillart et al.
Pathophysiological processes in multiple sclerosis: focus on nuclear factor erythroid-2-related factor 2 and emerging pathways.
Brain activity changes in cognitive networks in relapsing-remitting multiple sclerosis - insights from a longitudinal FMRI study.

Pages